Literature DB >> 512963

Inhibition by angiotensin II of baroreceptor-evoked activity in cardiac vagal efferent nerves in the dog.

E R Lumbers, D I McCloskey, E K Potter.   

Abstract

1. Action potentials were recorded in single baroreceptor fibres dissected from the carotid sinus nerves in dogs during increases in blood pressure caused by I.V. injection of angiotensin II, and by I.V. injection of phenylephrine or inflation of an aortic balloon. Action potentials were recorded in single cardiac efferent fibres dissected from the right cervical vagus nerve in other dogs during increases in blood pressure caused by angiotensin II, and by phenylephrine or by inflation of an aortic balloon. 2. There was no difference in the discharge frequency of single carotid sinus baroreceptor fibres at any blood pressure when phenylephrine, balloon inflation, or angiotensin II were used to raise the pressure. 3. Activity in single cardiac vagal efferent fibres was increased when blood pressure was increased by phenylephrine or by inflation of an aortic balloon. However, when blood pressure rose by a comparable amount in response to angiotensin II, vagal firing decreased (three fibres), was little changed from control levels (four fibres), or increased less than it did in response to phenylephrine (one fibre). 4. It is concluded that while angiotensin II has no effect on baroreceptor sensitivity, it does inhibit vagal discharge which is evoked by stimulation of arterial baroreceptors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 512963      PMCID: PMC1280542          DOI: 10.1113/jphysiol.1979.sp012915

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  20 in total

1.  ACTIVITY OF SINGLE VAGAL FIBERS EFFERENT TO THE HEART.

Authors:  J IRIUCHIJIMA; M KUMADA
Journal:  Jpn J Physiol       Date:  1964-10-15

2.  ACTIVITY OF SINGLE EFFERENT FIBRES IN THE CERVICAL VAGUS NERVE OF THE DOG, WITH SPECIAL REFERENCE TO POSSIBLE CARDIO-INHIBITORY FIBRES.

Authors:  D L JEWETT
Journal:  J Physiol       Date:  1964-12       Impact factor: 5.182

3.  Mechanisms of inhibition of heart rate by phenylephrine.

Authors:  S VARMA; S D JOHNSEN; D E SHERMAN; W B YOUMANS
Journal:  Circ Res       Date:  1960-11       Impact factor: 17.367

4.  Effect of synthetic angiotonin on the carotid sinus.

Authors:  J W MCCUBBIN; I H PAGE; F M BUMPUS
Journal:  Circ Res       Date:  1957-07       Impact factor: 17.367

5.  The physiologically relevant information regarding systemic blood pressure encoded in the carotid sinus baroreceptor discharge pattern.

Authors:  J O Arndt; J Morgenstern; L Samodelov
Journal:  J Physiol       Date:  1977-07       Impact factor: 5.182

6.  Muscular reflex and baroreflex influences on heart rate during isometric contractions.

Authors:  K A Streatfeild; N S Davidson; D I McCloskey
Journal:  Cardiovasc Res       Date:  1977-03       Impact factor: 10.787

7.  Respiratory modulation of baroreceptor and chemoreceptor reflexes affecting heart rate through the sympathetic nervous system.

Authors:  A L Davis; D I McCloskey; E K Potter
Journal:  J Physiol       Date:  1977-11       Impact factor: 5.182

8.  Inhibition of baroreceptor and chemoreceptor reflexes on heart rate by afferents from the lungs.

Authors:  S C Gandevia; D I McCloskey; E K Potter
Journal:  J Physiol       Date:  1978-03       Impact factor: 5.182

9.  Respiratory stimulation by angiotensin II.

Authors:  E K Potter; D I McCloskey
Journal:  Respir Physiol       Date:  1979-04

10.  The action of angiotensin II on the baroreflex response of the conscious ewe and the conscious fetus.

Authors:  M J Ismay; E R Lumbers; A D Stevens
Journal:  J Physiol       Date:  1979-03       Impact factor: 5.182

View more
  37 in total

Review 1.  Autonomic changes in patients with heart failure and in post-myocardial infarction patients.

Authors:  M P Frenneaux
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

2.  Effects of the angiotensin converting enzyme inhibitor, benazepril, on the sino-aortic baroreceptor heart rate reflex.

Authors:  J N West; P C Champion de Crespigny; T J Stallard; W A Littler
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

3.  Evaluation of amlodipine, lisinopril, and a combination in the treatment of essential hypertension.

Authors:  M U Naidu; P R Usha; T R Rao; J C Shobha
Journal:  Postgrad Med J       Date:  2000-06       Impact factor: 2.401

4.  Endogenous angiotensin II and baroreceptor dysfunction: a comparative study of losartan and enalapril in man.

Authors:  K M Yee; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

5.  Positive chronotropic activity of angiotensin II in the pithed normotensive rat is primarily due to activation of cardiac beta 1-adrenoceptors.

Authors:  J T Knape; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

6.  Response of cardiac sympathetic nerve activity to intravenous irbesartan in heart failure.

Authors:  Rohit Ramchandra; Anna M D Watson; Sally G Hood; Clive N May
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-02-10       Impact factor: 3.619

7.  Chronic angiotensin-II treatment potentiates HR slowing in Sprague-Dawley rat during acute behavioral stress.

Authors:  Richard E Hoyt; Richard O Speakman; David R Brown; Lisa A Cassis; Dennis L Silcox; Chikodi N Anigbogu; David C Randall
Journal:  Auton Neurosci       Date:  2013-01-11       Impact factor: 3.145

8.  A facilitatory effect of anti-angiotensin drugs on vagal bradycardia in the pithed rat and guinea-pig.

Authors:  M Rechtman; H Majewski
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

9.  Aortic baroreceptor characteristics in dogs with chronic high output failure.

Authors:  M J Niebauer; M J Holmberg; I H Zucker
Journal:  Basic Res Cardiol       Date:  1986 Mar-Apr       Impact factor: 17.165

10.  Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.

Authors:  J A Millar; F H Derkx; K McLean; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.